InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+45.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Garipalli Vivek, Director. Insider active across 1 company, notably Clover Health Investments, CORP. /de. In total, 8 reports have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €2.6m. Activity tracked since 17 June 2024. The latest transaction was disclosed on 7 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Garipalli Vivek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,655,949 shares0Class A Common StockSEC:0001801170-26-000013:0
415,000 shares@ US$2.240.065% mcap50.0% of flowClass A Common StockSEC:0001801170-25-000207:0
Canonical exit: 5 Nov 2025 (T+90)
1,670,965 shares0Class A Common StockSEC:0001801170-25-000027:0
531,700 shares@ US$1.8826.6% of flowClass A Common StockSEC:0001801170-24-000172:0
Canonical exit: 7 Nov 2024 (T+90)
877,567 shares@ US$1.1427.1% of flowClass A Common StockSEC:0001801170-24-000132:0
Canonical exit: 15 Sept 2024 (T+90)
1,561,065 sharesClass A Common StockSEC:0001801170-24-000039:0
1,569,594 sharesClass A Common StockSEC:0000895345-23-000261:0
3,342,698 sharesClass B Common StockSEC:0001628280-22-000730:0
8 of 8 declarations
About Garipalli Vivek
Vivek Garipalli is a Director and Chief Executive Officer of Clover Health Investments, Corp. /DE. He leads the company with a focus on strategy and growth. His experience in the health sector is an asset for developing innovative solutions.
